Canada Life’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.36M Buy
45,065
+24
+0.1% +$1.44K ﹤0.01% 1095
2025
Q4
$2.65M Sell
45,041
-3,369
-7% -$205K ﹤0.01% 1051
2025
Q3
$2.53M Buy
48,410
+360
+0.7% +$19.3K ﹤0.01% 1131
2025
Q2
$2.47M Sell
48,050
-16,419
-25% -$825K ﹤0.01% 1107
2025
Q1
$3.79M Sell
64,469
-7,772
-11% -$527K 0.01% 905
2024
Q4
$5.2M Buy
72,241
+979
+1% +$71.9K 0.01% 823
2024
Q3
$5.7M Buy
71,262
+4,566
+7% +$343K 0.01% 798
2024
Q2
$4.78M Buy
66,696
+7,898
+13% +$581K 0.01% 847
2024
Q1
$4.14M Buy
58,798
+4,457
+8% +$319K 0.01% 898
2023
Q4
$4.18M Buy
54,341
+3,893
+8% +$256K 0.01% 856
2023
Q3
$3.43M Sell
50,448
-695
-1% -$54.9K 0.01% 915
2023
Q2
$4.19M Sell
51,143
-2,846
-5% -$229K 0.01% 808
2023
Q1
$4.01M Sell
53,989
-72
-0.1% -$5.55K 0.01% 860
2022
Q4
$4.5M Sell
54,061
-21,267
-28% -$1.69M 0.01% 782
2022
Q3
$5.34M Sell
75,328
-344
-0.5% -$29.7K 0.02% 653
2022
Q2
$6.56M Sell
75,672
-8,672
-10% -$813K 0.02% 624
2022
Q1
$9.58M Sell
84,344
-2,900
-3% -$299K 0.02% 594
2021
Q4
$11.3M Buy
87,244
+1,216
+1% +$149K 0.02% 558
2021
Q3
$10.5M Sell
86,028
-14,724
-15% -$1.79M 0.02% 569
2021
Q2
$11.3M Buy
100,752
+39,636
+65% +$4.17M 0.03% 562
2021
Q1
$5.82M Sell
61,116
-4,188
-6% -$382K 0.01% 698
2020
Q4
$5.18M Sell
65,304
-7,880
-11% -$571K 0.01% 768
2020
Q3
$4.53M Sell
73,184
-3,744
-5% -$244K 0.01% 751
2020
Q2
$5.07M Sell
76,928
-2,464
-3% -$148K 0.01% 684
2020
Q1
$3.76M Buy
79,392
+5,956
+8% +$298K 0.01% 717
2019
Q4
$4M Buy
+73,436
New +$3.85M 0.01% 787
2019
Q3
Sell
-89,364
Closed -$4.66M 2153
2019
Q2
$4.66M Sell
89,364
-2,468
-3% -$124K 0.01% 757
2019
Q1
$4.56M Sell
91,832
-860
-0.9% -$38.7K 0.01% 676
2018
Q4
$3.11M Buy
92,692
+5,936
+7% +$248K 0.01% 804
2018
Q3
$4.43M Buy
86,756
+12
+0% +$532 0.01% 746
2018
Q2
$3.21M Sell
86,744
-3,652
-4% -$139K 0.01% 885
2018
Q1
$3.41M Buy
90,396
+2,988
+3% +$106K 0.01% 847
2017
Q4
$2.83M Sell
87,408
-2,800
-3% -$89K 0.01% 947
2017
Q3
$2.72M Buy
90,208
+1,172
+1% +$34.8K 0.01% 959
2017
Q2
$2.62M Buy
89,036
+564
+0.6% +$15.4K 0.01% 957
2017
Q1
$2.25M Buy
88,472
+3,244
+4% +$83.7K 0.01% 1051
2016
Q4
$2.19M Sell
85,228
-1,848
-2% -$48.6K 0.01% 1036
2016
Q3
$2.38M Buy
87,076
+1,760
+2% +$48.3K 0.01% 958
2016
Q2
$2.41M Buy
85,316
+70,284
+468% +$1.81M 0.01% 920
2016
Q1
$355K Hold
15,032
﹤0.01% 1020
2015
Q4
$338K Buy
15,032
+2,844
+23% +$64.9K ﹤0.01% 1027
2015
Q3
$282K Sell
12,188
-66,108
-84% -$1.66M ﹤0.01% 1066
2015
Q2
$1.93M Sell
78,296
-33,892
-30% -$846K 0.01% 807
2015
Q1
$2.81M Sell
112,188
-74,000
-40% -$1.76M 0.01% 741
2014
Q4
$4.31M Buy
186,188
+3,600
+2% +$82.4K 0.01% 646
2014
Q3
$4.27M Sell
182,588
-12,800
-7% -$300K 0.01% 644
2014
Q2
$4.51M Buy
195,388
+55,600
+40% +$1.23M 0.01% 630
2014
Q1
$2.97M Buy
139,788
+24,000
+21% +$540K 0.01% 724
2013
Q4
$2.75M Sell
115,788
-15,920
-12% -$345K 0.01% 719
2013
Q3
$2.63M Buy
131,708
+9,708
+8% +$184K 0.01% 694
2013
Q2
$2.11M Buy
+122,000
New +$2.03M 0.01% 399

Other funds holding TECH

Canada Life's TECH Position: Q1 2026 in Review

Canada Life increased its Bio-Techne (TECH) stake by 0.05% in Q1 2026, buying an estimated $1.44K and bringing the position to 45,065 shares worth $2.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1095.

Canada Life first reported a position in TECH in Q2 2013 and has held it in 51 quarters since. The position peaked at $11.3M in Q2 2021. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Canada Life held 45,065 shares of Bio-Techne worth $2.36M as of Q1 2026.
  • Canada Life bought 24 Bio-Techne shares in Q1 2026, an estimated $1.44K.
  • Bio-Techne made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1095 holding.
  • Canada Life first reported a position in Bio-Techne in Q2 2013 and has held it in 51 quarters since.
  • Canada Life's Bio-Techne position peaked at $11.3M in Q2 2021.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.